The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis
Abstract
BACKGROUND: Past sun exposure and vitamin D3 supplementation have been associated with a reduced risk of multiple sclerosis (MS). There are no previous longitudinal studies of vitamin D in MS. OBJECTIVES: To compare regulation of vitamin D and calcium homeostasis between patients with MS and healthy controls. To study the correlation of parameters of vitamin D metabolism with MS activity. METHODS: We measured 25-hydroxyvitamin D (25(OH)D), parathyroid hormone (PTH), calcium, phosphate, magnesium, chloride, alkaline phosphatase, albumin and thyroid stimulating hormone in serum every 3 months and at the time of relapse over 1 year in 23 patients with MS and in 23 healthy controls. MRI burden of disease and T2 activity were assessed every 6 months. RESULTS: Vitamin D deficiency (S-25(OH)D < or = 37 nmol/l) was common, affecting half of the patients and controls at some time in the year. Seasonal variation of 25(OH)D was similar in patients and controls, but 25(OH)D serum levels were lower and intact PTH (iPTH) serum levels were higher during MS relapses than in remission. All 21 relapses during the study occurred at serum iPTH levels > 20 ng/l (2.2 pmol/l), whereas 38% of patients in remission had iPTH levels < or = 20 ng/l. Patients with MS had a relative hypocalcaemia and a blunted PTH response in the winter. There was no correlation between serum 25(OH)D and MRI parameters. CONCLUSIONS: The endocrine circuitry regulating serum calcium may be altered in MS. There is an inverse relationship between serum vitamin D level and MS clinical activity. The role of vitamin D in MS must be explored further.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Van'T Hof, R. J., & Ralston, S. H. (2001) · Immunology · doi:10.1046/j.1365-2567.2001.01261.x · Cited by 518
Cited by
Vitamin D and multiple sclerosis
Ascherio, A., Munger, K. L., & Simon, K. C. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70086-7 · Cited by 576
Higher 25‐hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis
Simpson, S., Taylor, B., Blizzard, L., Ponsonby, A., Pittas, F., Tremlett, H., Dwyer, T., Gies, P., & van der Mei, I. (2010) · Annals of Neurology · doi:10.1002/ana.22043 · Cited by 457
Vitamin D and Immune Regulation: Antibacterial, Antiviral, Anti‐Inflammatory
L Bishop, E., Ismailova, A., Dimeloe, S., Hewison, M., & White, J. H. (2021) · JBMR Plus · doi:10.1002/jbm4.10405 · Cited by 392
A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis
Burton, J. M., Kimball, S., Vieth, R., Bar-Or, A., Dosch, H.-M., Cheung, R., Gagne, D., D'Souza, C., Ursell, M., & O'Connor, P. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e1cec2 · Cited by 360
Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis
Smolders, J., Menheere, P., Kessels, A., Damoiseaux, J., & Hupperts, R. (2008) · Multiple Sclerosis Journal · doi:10.1177/1352458508094399 · Cited by 340
Vitamin D as an immune modulator in multiple sclerosis, a review
Smolders, J., Damoiseaux, J., Menheere, P., & Hupperts, R. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.11.014 · Cited by 317
The Implication of Vitamin D and Autoimmunity: a Comprehensive Review
Yang, C.-Y., Leung, P. S. C., Adamopoulos, I. E., & Gershwin, M. E. (2013) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-013-8361-3 · Cited by 299
Antico, A., Tampoia, M., Tozzoli, R., & Bizzaro, N. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.07.007 · Cited by 297
Soilu-Hänninen, M., Åivo, J., Lindström, B.-M., Elovaara, I., Sumelahti, M.-L., Färkkilä, M., Tienari, P., Atula, S., Sarasoja, T., Herrala, L., et al. (2012) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301876 · Cited by 269
Environmental factors and their timing in adult-onset multiple sclerosis
Handel, A. E., Giovannoni, G., Ebers, G. C., & Ramagopalan, S. V. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.1 · Cited by 263
A systematic review of modifiable risk factors in the progression of multiple sclerosis
Hempel, S., Graham, G. D., Fu, N., Estrada, E., Chen, A. Y., Miake-Lye, I., Miles, J. N. V., Shanman, R., Shekelle, P. G., Beroes, J. M., et al. (2017) · Multiple Sclerosis Journal · doi:10.1177/1352458517690270 · Cited by 77
Bhargava, P., Cassard, S., Steele, S. U., Azevedo, C., Pelletier, D., Sugar, E. A., Waubant, E., & Mowry, E. M. (2014) · Contemporary Clinical Trials · doi:10.1016/j.cct.2014.10.004 · Cited by 69
Metadata
- Authors
- Soilu-Hanninen, M., Laaksonen, M., Laitinen, I., Eralinna, J.-P., Lilius, E.-M., & Mononen, I.
- Venue
- Journal of Neurology, Neurosurgery & Psychiatry
- Publisher
- BMJ
- Published
- 2008-02-01
- Volume
- 79
- Issue
- 2
- Pages
- 152-157
- ISSN
- 0022-3050 (ISSN-L)
- OpenAlex
- W2155048481
- Cited by
- 206
- References
- 1
- FWCI
- 9.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.